VTv Therapeutics Correlations
VTVT Stock | USD 17.03 0.00 0.00% |
The current 90-days correlation between vTv Therapeutics and Kezar Life Sciences is -0.1 (i.e., Good diversification). The correlation of VTv Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
VTv Therapeutics Correlation With Market
Significant diversification
The correlation between vTv Therapeutics and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding vTv Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving against VTv Stock
0.82 | CGEN | Compugen | PairCorr |
0.8 | KB | KB Financial Group | PairCorr |
0.77 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
0.74 | WF | Woori Financial Group Earnings Call Tomorrow | PairCorr |
0.68 | PFE | Pfizer Inc | PairCorr |
0.68 | FNMFO | Federal National Mortgage Earnings Call This Week | PairCorr |
0.65 | KMDA | Kamada | PairCorr |
0.51 | NKTR | Nektar Therapeutics | PairCorr |
0.51 | AVAL | Grupo Aval | PairCorr |
0.51 | BAC-PL | Bank of America | PairCorr |
0.4 | EVGN | Evogene | PairCorr |
0.36 | RCUS | Arcus Biosciences | PairCorr |
0.32 | JNJ | Johnson Johnson | PairCorr |
0.79 | IBM | International Business Earnings Call Tomorrow | PairCorr |
0.75 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
0.71 | DIS | Walt Disney | PairCorr |
0.69 | MSFT | Microsoft Earnings Call Next Week | PairCorr |
0.64 | CVX | Chevron Corp | PairCorr |
0.63 | AXP | American Express | PairCorr |
0.58 | AA | Alcoa Corp | PairCorr |
0.55 | T | ATT Inc Earnings Call Tomorrow | PairCorr |
0.36 | INTC | Intel Earnings Call This Week | PairCorr |
Related Correlations Analysis
0.33 | 0.0 | -0.79 | 0.82 | -0.67 | XBIO | ||
0.33 | 0.0 | -0.48 | 0.11 | -0.12 | KZR | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | PBLA | ||
-0.79 | -0.48 | 0.0 | -0.63 | 0.6 | OGEN | ||
0.82 | 0.11 | 0.0 | -0.63 | -0.68 | SLS | ||
-0.67 | -0.12 | 0.0 | 0.6 | -0.68 | DARE | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between VTv Stock performing well and VTv Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze VTv Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
XBIO | 3.79 | 0.75 | 0.13 | (2.72) | 3.92 | 9.67 | 34.70 | |||
KZR | 2.60 | (0.02) | (0.01) | 0.12 | 3.48 | 5.17 | 16.72 | |||
PBLA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
OGEN | 6.46 | (1.41) | 0.00 | (3.54) | 0.00 | 11.11 | 101.09 | |||
SLS | 4.03 | 0.48 | 0.11 | 0.49 | 4.32 | 10.00 | 23.23 | |||
DARE | 2.36 | (0.04) | 0.00 | 0.31 | 0.00 | 5.16 | 30.71 |
VTv Therapeutics Corporate Management
David III | Sr Counsel | Profile | |
Carmen Valcarce | Chief VP | Profile | |
MD FACC | Executive Chairperson | Profile | |
Martin Lafontaine | Chief Officer | Profile |